seed
Stage
1
Investors
About
Ligandal develops bioinspired nanomaterials and peptide-based targeting technologies to improve targeted delivery of therapeutics, gene therapies, and diagnostics. The company focuses on delivery solutions for precision genetic medicine and related drug development.
Explore Ligandal's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.